Back to Essential Thrombocythaemia

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  2. Myeloproliferative Neoplastic Diseases Observatory From Brest

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  3. INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-01

    View record
  4. Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm

    RECRUITING → ACTIVE NOT RECRUITING

    Recorded 2026-10-01

    View record
  5. Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

    COMPLETED → TERMINATED

    Recorded 2026-10-01

    View record